A Unique Infusion Reaction to Vedolizumab in a Patient With Crohn's Disease

Gastroenterology. 2018 Oct;155(4):981-982. doi: 10.1053/j.gastro.2018.03.048. Epub 2018 Apr 1.

Authors

Stephanie L Gold¹, Cynthia Magro², Ellen Scherl³

Affiliations

¹ Department of Medicine, New York Presbyterian Weill Cornell Medical College, New York, New York.
² Department of Pathology and Laboratory Medicine, New York Presbyterian Weill Cornell Medical College, New York, New York.
³ Department of Gastroenterology and Hepatology, New York Presbyterian Weill Cornell Medical College, New York, New York.

PMID: 29614303
DOI: 10.1053/j.gastro.2018.03.048

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / administration & dosage
Antibodies, Monoclonal, Humanized / adverse effects*
Biopsy
Crohn Disease / diagnosis
Crohn Disease / drug therapy*
Crohn Disease / immunology
Drug Eruptions / diagnosis
Drug Eruptions / etiology*
Gastrointestinal Agents / administration & dosage
Gastrointestinal Agents / adverse effects*
Humans
IgA Vasculitis / chemically induced*
IgA Vasculitis / diagnosis
Infusions, Parenteral
Male
Middle Aged
Skin / drug effects*
Skin / pathology

Substances

Antibodies, Monoclonal, Humanized
Gastrointestinal Agents
vedolizumab